GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Median PS Value

Abingdon Health (LSE:ABDX) Median PS Value : £0.00 (As of Jun. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Abingdon Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.018. Abingdon Health's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is £0.00.

As of today (2024-06-01), Abingdon Health's share price is £0.1075. Abingdon Health's Median PS Value is £0.00. Therefore, Abingdon Health's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Abingdon Health's Median PS Value or its related term are showing as below:

LSE:ABDX's Price-to-Median-PS-Value is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.825
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Abingdon Health Median PS Value Historical Data

The historical data trend for Abingdon Health's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Median PS Value Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Median PS Value
Get a 7-Day Free Trial - - - - -

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abingdon Health's Median PS Value

For the Diagnostics & Research subindustry, Abingdon Health's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Price-to-Median-PS-Value falls into.



Abingdon Health Median PS Value Calculation

Abingdon Health's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.018*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abingdon Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.018.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health  (LSE:ABDX) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Abingdon Health's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.1075/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health Median PS Value Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (LSE:ABDX) Business Description

Traded in Other Exchanges
N/A
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines